title: Cyclophosphamide exposure in pediatric systemic lupus erythematosus is associated with reduced serum anti-mullerian hormone levels.
authors.forename: Josephine
authors.initials: J
authors.lastname: Isgro
authors.forename: Sahadat K
authors.initials: SK
authors.lastname: Nurudeen
authors.forename: Lisa F
authors.initials: LF
authors.lastname: Imundo
authors.forename: Mark V
authors.initials: MV
authors.lastname: Sauer
authors.forename: Nataki C
authors.initials: NC
authors.lastname: Douglas
mesh_terms: D000293:Adolescent; D054304:Anti-Mullerian Hormone / Q000097:blood*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy*; D012307:Risk Factors; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents; D054304:Anti-Mullerian Hormone; D003520:Cyclophosphamide